{"disease":{"id":"neuroendocrine-tumor-of-the-lung","name":"neuroendocrine tumor of the lung"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06472388","title":"Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"AC Camargo Cancer Center","has_results":false},{"nct_id":"NCT06148636","title":"A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors","phase":"EARLY_PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":24,"lead_sponsor_name":"David Bushnell","has_results":false},{"nct_id":"NCT05557708","title":"A Safety Study of 212Pb-Pentixather Radioligand Therapy","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Yusuf Menda","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}